Rockwell Medical, Inc. (RMTI)

NASDAQ: RMTI · IEX Real-Time Price · USD
1.950
+0.050 (2.63%)
Jul 19, 2024, 1:21 PM EDT - Market open
2.63%
Market Cap 59.12M
Revenue (ttm) 86.62M
Net Income (ttm) -8.42M
Shares Out 30.32M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,531
Open 1.880
Previous Close 1.900
Day's Range 1.880 - 1.950
52-Week Range 1.160 - 4.280
Beta 1.43
Analysts Strong Buy
Price Target 7.00 (+258.97%)
Earnings Date Aug 8, 2024

About RMTI

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. Also, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products,... [Read more]

Sector Healthcare
IPO Date Jan 27, 1998
Employees 237
Stock Exchange NASDAQ
Ticker Symbol RMTI
Full Company Profile

Financial Performance

In 2023, RMTI's revenue was $83.61 million, an increase of 14.84% compared to the previous year's $72.81 million. Losses were -$8.44 million, -54.82% less than in 2022.

Financial Statements

Analyst Forecast

According to 2 analysts, the average rating for RMTI stock is "Strong Buy." The 12-month stock price forecast is $7.0, which is an increase of 258.97% from the latest price.

Price Target
$7.0
(258.97% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Rockwell Medical to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's president and CEO, Dr. Mark Strobeck, to present at the H.C. Wainwright 3rd Annual Kidney Conference.

4 days ago - Business Wire

Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the second quarter ended June 30, 2024 on Thursday, August 8, 20...

8 days ago - Business Wire

Rockwell Medical Promotes Tim Chole to Chief Commercial Officer

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Mr. Chole has played a key role in helping Rockwell Medical increase its market share and broaden its product portfolio.

7 weeks ago - Business Wire

Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical (Nasdaq: RMTI) today announced financial and operational results for the three months ended March 31, 2024.

2 months ago - Business Wire

Rockwell Medical Continues to Expand its Distribution Capabilities in Western United States

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into a new direct supply agreement with one of the largest health systems in the Mountain West Region of the Uni...

3 months ago - Business Wire

Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the first quarter ended March 31, 2024 on Tuesday, May 14, 2024.

3 months ago - Business Wire

Rockwell Medical Expands Global Distribution in the Dominican Republic and Bermuda

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical enters into new and expanded distribution agreements with BioNuclear and Atlantic Medical International, respectively.

3 months ago - Business Wire

Rockwell Medical Named 'Great Place to Work' for Second Year in a Row

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it has been certified as a Great Place to Work® for the second year in a row.

4 months ago - Business Wire

Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...

4 months ago - Business Wire

Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the fourth quarter and full-year ended December 31, 2023 on Thursday, March 21, 2024.

5 months ago - Business Wire

Rockwell Medical Amends Loan and Security Agreement with Innovatus Life Sciences Lending Fund

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Defers principal payments of $8M up to 3yrs, reduces Rockwell Medical's need for additional operating capital, and enhances the Company'...

6 months ago - Business Wire

Rockwell Medical Announces Third Quarter 2023 Results

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes...

8 months ago - Business Wire

Rockwell Medical Names Jesse Neri as Senior Vice President, Finance

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Jesse Neri has 20+ years' experience leading finance functions at both public and private companies.

9 months ago - Business Wire

Rockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of Directors

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Dr. Joan Lau brings 20+ years of experience as an entrepreneur scientist, CEO, operator, investor, and board member of public and privat...

9 months ago - Business Wire

Rockwell Medical to Release Third Quarter 2023 Results on Tuesday, November 14, 2023

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the third quarter ended September 30, 2023 on Tuesday, November ...

9 months ago - Business Wire

Rockwell Medical Enters into 3-Year Product Purchase Agreement with Centers for Dialysis Care

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #ESRD--Rockwell Medical is honored to be entrusted by Centers for Dialysis Care to be its preferred supplier of hemodialysis concentrates.

10 months ago - Business Wire

Rockwell Medical Enters into 3-Year Product Purchase Agreement with Sanderling Renal Services; Expands Distribution Capabilities Westward into Utah

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical is the preferred supplier of liquid and dry acid and bicarbonate hemodialysis concentrates to Sanderling Renal Services...

10 months ago - Business Wire

Rockwell Medical Enters into Products Purchase Agreement with its Largest Customer, Enhancing Relationship through 2024

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical today announced that it entered into an amended and restated products purchase agreement with its largest customer.

10 months ago - Business Wire

Rockwell Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference on Tuesday, September 12, 2023

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical's President and CEO, Dr. Mark Strobeck, will present at H.C. Wainwright's conference on September 12, 2023 at 11:00 am ...

11 months ago - Business Wire

Rockwell Medical Announces Second Quarter 2023 Results

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #Hemodialysis--Rockwell Medical updated its guidance on profitability and now expects the Company to be profitable in the fourth quarter 2023 and going forward.

1 year ago - Business Wire

Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

1 year ago - Business Wire

Rockwell Medical to Release Second Quarter 2023 Financial Results on Monday, August 14, 2023

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its financial and operational results for the second quarter ended June 30, 2023 on Monday, August 14, 202...

1 year ago - Business Wire

Rockwell Medical Acquires Hemodialysis Concentrates Business from Evoqua Water Technologies

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical acquires the hemodialysis concentrates business from Evoqua Water Technologies; Adds fully automated and profitable bus...

1 year ago - Business Wire

Rockwell Medical Announces 3-Year Co-Promotional Collaboration with B. Braun Medical

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #Collaboration--Rockwell Medical entered into a three-year co-promotion services agreement with B. Braun Medical Inc.

1 year ago - Business Wire

Rockwell Medical Added to Russell Microcap Index

WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #RussellRecon--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfo...

1 year ago - Business Wire